Your browser doesn't support javascript.
loading
Engineering a multi-target therapy nanoplatform against tumor growth and metastasis via a novel NSAID-Pt(IV) prodrug.
Zhang, Di; Nie, Jing; Wang, Dongbo; Wu, Huina; Sun, Lei; Wang, Xuejian; Wu, Jiyong.
Afiliação
  • Zhang D; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
  • Nie J; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
  • Wang D; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
  • Wu H; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
  • Sun L; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
  • Wang X; School of Pharmacy, Weifang Medical University, Weifang, Shandong Province 261053, China.
  • Wu J; Department of Pharmacy, Shandong Second Provincial General Hospital, 4 West Duanxing Road, Jinan, Shandong Province 250022, China. wujiyongsdcn@gmail.com.
Chem Commun (Camb) ; 58(23): 3803-3806, 2022 Mar 18.
Article em En | MEDLINE | ID: mdl-35229844
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Chem Commun (Camb) Assunto da revista: QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Chem Commun (Camb) Assunto da revista: QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China